β-Cyclodextrin-poly (β-Amino Ester) Nanoparticles Are a Generalizable Strategy for High Loading and Sustained Release of HDAC Inhibitors
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
β-Cyclodextrin-poly (β-Amino Ester) Nanoparticles Are a Generalizable Strategy for High Loading and Sustained Release of HDAC Inhibitors
Authors
Keywords
-
Journal
ACS Applied Materials & Interfaces
Volume 13, Issue 18, Pages 20960-20973
Publisher
American Chemical Society (ACS)
Online
2021-04-28
DOI
10.1021/acsami.0c22587
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- PET, image-guided HDAC inhibition of pediatric diffuse midline glioma improves survival in murine models
- (2020) Umberto Tosi et al. Science Advances
- Ionic Polymethacrylate Based Delivery Systems: Effect of Carrier Topology and Drug Loading
- (2019) Dorota Neugebauer et al. Pharmaceutics
- pH driven precipitation of quisinostat onto PLA-PEG nanoparticles enables treatment of intracranial glioblastoma
- (2018) Kyle T. Householder et al. COLLOIDS AND SURFACES B-BIOINTERFACES
- The distribution, clearance, and brainstem toxicity of panobinostat administered by convection-enhanced delivery
- (2018) William G. B. Singleton et al. Journal of Neurosurgery-Pediatrics
- Evolution of Cyclodextrin Nanosponges
- (2017) Fabrizio Caldera et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Inhibition of histone deacetylases in cancer therapy: lessons from leukaemia
- (2016) Elena Ceccacci et al. BRITISH JOURNAL OF CANCER
- HDAC and PI3K Antagonists Cooperate to Inhibit Growth of MYC- Driven Medulloblastoma
- (2016) Yanxin Pei et al. CANCER CELL
- CRLX101 nanoparticles localize in human tumors and not in adjacent, nonneoplastic tissue after intravenous dosing
- (2016) Andrew J. Clark et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Histone deacetylase inhibitors for the treatment of cancer stem cells
- (2016) M. Dvorakova et al. MedChemComm
- Analysis of nanoparticle delivery to tumours
- (2016) Stefan Wilhelm et al. Nature Reviews Materials
- Nanoparticle formulations of histone deacetylase inhibitors for effective chemoradiotherapy in solid tumors
- (2015) Edina C. Wang et al. BIOMATERIALS
- Cyclodextrin nanoassemblies: a promising tool for drug delivery
- (2015) Véronique Bonnet et al. DRUG DISCOVERY TODAY
- Iron Complexation to Histone Deacetylase Inhibitors SAHA and LAQ824 in PEGylated Liposomes Can Considerably Improve Pharmacokinetics in Rats
- (2015) Yan Wang et al. JOURNAL OF PHARMACY AND PHARMACEUTICAL SCIENCES
- PLGA-PEG Nanoparticles Coated with Anti-CD45RO and Loaded with HDAC Plus Protease Inhibitors Activate Latent HIV and Inhibit Viral Spread
- (2015) Xiaolong Tang et al. Nanoscale Research Letters
- PLGA-PEG Nanoparticles Coated with Anti-CD45RO and Loaded with HDAC Plus Protease Inhibitors Activate Latent HIV and Inhibit Viral Spread
- (2015) Xiaolong Tang et al. Nanoscale Research Letters
- Mesoporous Silica Nanoparticles Coated by Layer-by-Layer Self-assembly Using Cucurbit[7]uril for in Vitro and in Vivo Anticancer Drug Release
- (2014) Qing-Lan Li et al. CHEMISTRY OF MATERIALS
- Development of lipid nanoparticles for a histone deacetylases inhibitor as a promising anticancer therapeutic
- (2014) Tuan Hiep Tran et al. DRUG DELIVERY
- Histone deacetylase inhibitors promote glioma cell death by G2 checkpoint abrogation leading to mitotic catastrophe
- (2014) M Cornago et al. Cell Death & Disease
- A Phase I Study of Quisinostat (JNJ-26481585), an Oral Hydroxamate Histone Deacetylase Inhibitor with Evidence of Target Modulation and Antitumor Activity, in Patients with Advanced Solid Tumors
- (2013) B. Venugopal et al. CLINICAL CANCER RESEARCH
- The pan-histone deacetylase inhibitor LBH589 (panobinostat) alters the invasive breast cancer cell phenotype
- (2013) NICOLETTA FORTUNATI et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Initial testing (stage 1) of the histone deacetylase inhibitor, quisinostat (JNJ-26481585), by the Pediatric Preclinical Testing Program
- (2013) Hernan Carol et al. PEDIATRIC BLOOD & CANCER
- Inhibition of Histone Deacetylase Impacts Cancer Stem Cells and Induces Epithelial-Mesenchyme Transition of Head and Neck Cancer
- (2013) Fernanda S. Giudice et al. PLoS One
- Effect of Zeta Potential on the Properties of Nano-Drug Delivery Systems - A Review (Part 1)
- (2013) S Honary et al. TROPICAL JOURNAL OF PHARMACEUTICAL RESEARCH
- β-Cyclodextrin-poly(β-Amino Ester) Nanoparticles for Sustained Drug Delivery across the Blood–Brain Barrier
- (2012) Eun Seok Gil et al. BIOMACROMOLECULES
- Vorinostat with sustained exposure and high solubility in poly(ethylene glycol)‐b‐poly(dl‐lactic acid) micelle nanocarriers: Characterization and effects on pharmacokinetics in rat serum and urine
- (2012) Elham A. Mohamed et al. JOURNAL OF PHARMACEUTICAL SCIENCES
- Angiopep-conjugated poly(ethylene glycol)-co-poly(ε-caprolactone) nanoparticles as dual-targeting drug delivery system for brain glioma
- (2011) Hongliang Xin et al. BIOMATERIALS
- Effects of particle size and surface charge on cellular uptake and biodistribution of polymeric nanoparticles
- (2010) Chunbai He et al. BIOMATERIALS
- Expression of nuclear receptor corepressors and class I histone deacetylases in astrocytic gliomas
- (2010) Benito Campos et al. CANCER SCIENCE
- Activity of deacetylase inhibitor panobinostat (LBH589) in cutaneous T-cell lymphoma models: Defining molecular mechanisms of resistance
- (2010) Wenlin Shao et al. INTERNATIONAL JOURNAL OF CANCER
- Liposomes loaded with histone deacetylase inhibitors for breast cancer therapy
- (2010) Giorgia Urbinati et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Synthesis and in vitro/in vivo anti-cancer evaluation of curcumin-loaded chitosan/poly(butyl cyanoacrylate) nanoparticles
- (2010) Jinghua Duan et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- The synergistic effect of panobinostat (LBH589) with melphalan or doxorubicin on multiple myeloma cells; rationale for the use of combination regimens in myeloma patients
- (2010) Evangelos Terpos LEUKEMIA RESEARCH
- JNJ-26481585, a Novel "Second-Generation" Oral Histone Deacetylase Inhibitor, Shows Broad-Spectrum Preclinical Antitumoral Activity
- (2009) J. Arts et al. CLINICAL CANCER RESEARCH
- Comparative evaluation of polymeric and amphiphilic cyclodextrin nanoparticles for effective camptothecin delivery
- (2009) Yasemin Çirpanli et al. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS
- Histone deactylase inhibition combined with behavioral therapy enhances learning and memory following traumatic brain injury
- (2009) P.K. Dash et al. NEUROSCIENCE
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started